NEW YORK, Feb. 8, 2017 /PRNewswire/ -- The federal multidistrict litigation established last year for Taxotere permanent hair loss claims continues to move forward in the U.S. District Court, Eastern District of Louisiana. According to court documents, the litigation convened its most recent status conference on January 27th. Per a Joint Report of Liaison Counsel posted on the Court's website, at least 766 Taxotere lawsuits have either been filed in or transferred to the proceeding. Taxotere litigations are also underway in Missouri and California state courts, while a number of cases have been filed in Delaware. The parties are making efforts to coordinate with counsel to apprise them of the Court's willingness to cooperate with the state court judges for the purposes of coordinating discovery and other pretrial proceedings. (In Re: Taxotere (Docetaxal) Products Liability Litigation - MDL No. 2740)
The Report also noted that the Plaintiffs' and Defendants' Settlement Committees have had multiple telephone discussions and have held an initial in-person meeting to discuss regular meetings. The Settlement Committees are tasked with maintaining a continuing collaborative discussion regarding a framework for potential resolution of the Taxotere litigation.
"Our Firm has been contacted by numerous cancer survivors who experienced permanent alopecia, allegedly due to Taxotere side effects. We are pleased that more progress has been made in the federal litigation, and will continue to monitor developments in these cases," says Sandy A. Liebhard, a partner at Bernstein Liebhard LLP, a nationwide law firm representing victims of defective medical devices and drugs. The Firm is now offering free case reviews to breast cancer patients and others whose hair failed to grow back following chemotherapy with Taxotere.
Taxotere Hair Loss Allegations
Taxotere is a chemotherapy agent marketed by Sanofi-Aventis. It was initially approved to treat breast cancer in 1996, and is now indicated for head and neck cancer, gastric cancer, prostate cancer and non-small cell lung cancer. While Sanofi has marketed Taxotere for two decades, it wasn't until December 2015 that any information regarding reports of permanent hair loss was included on its U.S. label. While alopecia is a common side effect of chemotherapy, plaintiffs claim that Taxotere is more likely to cause the permanent loss of hair compared to alternative, equally effective agents. While Sanofi did provide information regarding the potential for permanent hair loss to individual patients and regulatory agencies overseas, Taxotere plaintiffs claim that the U.S. label only included a generic, vague, and insufficient warning that "hair generally grows back"
Taxotere patients may be entitled to compensation if they experienced permanent alopecia following treatment. To learn more about Taxotere lawsuits, please visit Bernstein Liebhard LLP's website, or call 800-511-5092 to arrange for a free, no obligation case review.
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3.5 billion on behalf of our clients. Bernstein Liebhard LLP is honored to once again be named to The National Law Journal's "Plaintiffs' Hot List," recognizing the top plaintiffs firms in the country. This year's nomination marks the thirteenth year the firm has been named to this prestigious annual list.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2017 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Sandy A. Liebhard, Esq.
Bernstein Liebhard LLP
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/taxotere-lawsuit-attorneys-at-bernstein-liebhard-llp-discuss-most-recent-status-conference-in-federal-hair-loss-litigation-300404458.html
SOURCE Bernstein Liebhard LLP